{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:34:41Z","timestamp":1790948081001,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.numecd.2020.09.014","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T02:08:42Z","timestamp":1600654122000},"page":"626-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-2799","authenticated-orcid":false,"given":"Mona","family":"Alshahawey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"El borolossy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"El Wakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa Ali","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2020.09.014_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2803579","article-title":"Role of vitamin D in uremic vascular calcification","volume":"2017","author":"Hou","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.numecd.2020.09.014_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41100-017-0094-y","article-title":"Impact of vascular calcification on cardiovascular mortality in hemodialysis patients: clinical significance, mechanisms and possible strategies for treatment","volume":"3","author":"Ohtake","year":"2017","journal-title":"Renal Replace Therapy"},{"key":"10.1016\/j.numecd.2020.09.014_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","article-title":"Vascular calcification: mechanisms and clinical ramifications","volume":"24","author":"Abedin","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2020.09.014_bib4","series-title":"Vitamin D and cardiovascular calcification in chronic kidney disease. Vitamin D in chronic kidney disease","first-page":"361","author":"H\u00e9naut","year":"2016"},{"key":"10.1016\/j.numecd.2020.09.014_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2020.09.014_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cca.2014.08.034","article-title":"Vascular calcification: from pathophysiology to biomarkers","volume":"438","author":"Evrard","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2020.09.014_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7150\/ijbs.3886","article-title":"Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease","volume":"8","author":"Hu","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.numecd.2020.09.014_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1797.2012.01618.x","article-title":"Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk","volume":"17","author":"Toussaint","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.numecd.2020.09.014_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2020.09.014_bib10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/ndt\/gfh263","article-title":"Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients","volume":"19","author":"Nitta","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000321169","article-title":"Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients","volume":"117","author":"Kurnatowska","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.numecd.2020.09.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.11.029","article-title":"Pleiotropic effects of vitamin D in chronic kidney disease","volume":"453","author":"Liu","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2020.09.014_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/M14-1659","article-title":"Screening for vitamin D deficiency: a systematic review for the US preventive services task force","volume":"162","author":"LeBlanc","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2020.09.014_bib14","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.numecd.2020.09.014_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","article-title":"Vitamin D therapy in chronic kidney disease and end stage renal disease","volume":"7","author":"Melamed","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/gfn502","article-title":"25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients","volume":"24","author":"Matias","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.ajkd.2014.04.020","article-title":"Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial randomized trial","volume":"64","author":"Massart","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2020.09.014_bib18","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/ndt\/gfn367","article-title":"High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients","volume":"23","author":"Tokmak","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib19","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/ndt\/gfp370","article-title":"Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3945\/ajcn.111.025502","article-title":"Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis","volume":"95","author":"Wasse","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2020.09.014_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179540","article-title":"Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: a randomized controlled pilot trial","volume":"12","author":"Carvalho","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2020.09.014_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2020.09.014_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1172\/JCI108459","article-title":"Radioligand receptor assay for 25-hydroxyvitamin D2\/D3 and 1 alpha, 25-dihydroxyvitamin D2\/D3","volume":"58","author":"Hughes","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2020.09.014_bib26","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1093\/ndt\/gfn339","article-title":"Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers","volume":"23","author":"Jean","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5301\/jn.5000123","article-title":"Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study","volume":"26","author":"Daroux","year":"2013","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrcardio.2016.73","article-title":"Vitamin D and cardiovascular disease prevention","volume":"13","author":"Pilz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2020.09.014_bib29","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein \u03b1 2\u2013Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Sch\u00e4fer","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2020.09.014_bib31","first-page":"285","article-title":"Vascular calcification in chronic kidney disease: mechanisms and clinical implications","volume":"5","author":"Ossareh","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.numecd.2020.09.014_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-012-1500-y","article-title":"Biochemical markers of vascular calcification in elderly hemodialysis patients","volume":"374","author":"Osorio","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.numecd.2020.09.014_bib33","series-title":"Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients. Seminars in dialysis","year":"2018"},{"key":"10.1016\/j.numecd.2020.09.014_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-14-122","article-title":"Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients","volume":"14","author":"Pateinakis","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.2010.357","article-title":"Increased fetuin-A levels following treatment with a vitamin D analog","volume":"78","author":"Manenti","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2020.09.014_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2369-15-130","article-title":"The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study","volume":"15","author":"Hansen","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib37","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/ndt\/gft001","article-title":"Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study","volume":"28","author":"Delanaye","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2020.09.014_bib38","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in\u00a0vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2020.09.014_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2015.10.031","article-title":"Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients","volume":"452","author":"Lee","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2020.09.014_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/0886022X.2013.781844","article-title":"Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients","volume":"35","author":"Chen","year":"2013","journal-title":"Ren Fail"},{"key":"10.1016\/j.numecd.2020.09.014_bib41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages","volume":"23","author":"Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.numecd.2020.09.014_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1681\/ASN.2009040451","article-title":"Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD","volume":"21","author":"Stubbs","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2020.09.014_bib44","first-page":"121","article-title":"FGF23 induces left ventricular hypertrophy","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2020.09.014_bib45","article-title":"Renal transplantation decreases osteoprotegerin levels","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.numecd.2020.09.014_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/14397595.2014.926852","article-title":"Changes of plasma concentration of osteoprotegerin and its association with endothelial dysfunction before and after hypouricemic therapy in patients with hyperuricemia","volume":"25","author":"Wang","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.numecd.2020.09.014_bib47","first-page":"1","article-title":"Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial","author":"Ramirez-Sandoval","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib48","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11255-017-1643-6","article-title":"The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial","volume":"49","author":"Zakaria","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.numecd.2020.09.014_bib49","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1542-4758.2007.00224.x","article-title":"Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study","volume":"11","author":"Othmane","year":"2007","journal-title":"Hemodial Int"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320304014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:16:12Z","timestamp":1760544972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475320304014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0939475320304014"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2020.09.014","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2020.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}